View Full Paper

Research Aim, Objectives, and Questions

Critical Examination of Innovation Hubs as Catalysts for ATMP Development

This research aims to critically explore how innovation hubs in emerging markets function as strategic enablers for the acceleration of Advanced Therapy Medicinal Products (ATMPs), with a particular focus on the interaction between policy frameworks, investment dynamics, and cross-sectoral collaboration.

Research Objectives for Evaluating Innovation Hub Performance and Effectiveness

• To investigate the structural and functional configurations of innovation hubs that support ATMP development in selected emerging markets.
• To analyse the influence of national innovation policies, regulatory environments, and institutional governance on the ability of hubs to accelerate ATMP pipelines.
• To assess the role of investment flows, funding models, and public-private partnerships (PPPs) in enhancing the operational capacity and performance of innovation hubs.
• To identify context-specific barriers and enablers that shape the effectiveness of innovation hubs in translating ATMP research into commercially viable and clinically impactful therapies.

Research Questions Guiding the Investigation of Innovation Hub Contributions to ATMP Acceleration

• In what ways are innovation hubs in India, Brazil, and China structurally organised and functionally designed to support the development and acceleration of ATMPs?
• How do national policy instruments and regulatory regimes impact the strategic effectiveness of innovation hubs in advancing ATMP innovation?
• What is the role of financial mechanisms in shaping innovation hub performance and ATMP translation outcomes?
• What challenges and success factors do innovation hubs face in resource-constrained contexts?